The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Bavarian Nordic A/S
F:BV3A
|
DK |
|
C
|
C3 Metals Inc
OTC:CUAUF
|
CA |
|
V
|
Victory Square Technologies Inc
F:6F6
|
CA |
|
T
|
Tempus Capital Inc
CNSX:TEMP
|
CA |
|
W
|
Wave Entertainment PCL
SET:WAVE
|
TH |
|
E
|
Earthwise Minerals Corp
CNSX:WISE
|
CA |
|
IRSA Inversiones y Representaciones SA
F:IRY
|
AR |
|
P
|
Prakit Holdings PCL
SET:PRAKIT
|
TH |
|
B
|
Bezvavlasy as
PSE:BEZVA
|
CZ |
|
Energi Mega Persada Tbk PT
OTC:PEGIY
|
ID |
|
N
|
Nissan Chemical Corp
SWB:NSC
|
JP |
|
Molecule Holdings Inc
F:ERV2
|
CA |
|
Banca Profilo SpA
MIL:PRO
|
IT |
|
Musashi Seimitsu Industry Co Ltd
F:67X
|
JP |
|
W
|
Wiit SpA
MIL:WIIT
|
IT |
|
B
|
Bangkok Dec-Con PCL
SET:BKD
|
TH |
|
Christian Dior SE
PAR:CDI
|
FR |
|
N
|
Newpath Resources Inc
CNSX:PATH
|
CA |
|
Sixty North Gold Mining Ltd
F:2F40
|
CA |
|
PCB Bancorp
F:9UH
|
US |
|
M
|
Market Connections Asia PCL
SET:MCA
|
TH |
|
A
|
Advanced Connection Corporation PCL
SET:ACC
|
TH |
|
A
|
Andritz AG
XMUN:AZ2
|
AT |
|
A
|
AIM ImmunoTech Inc
AMEX:AIM
|
US |
Bavarian Nordic A/S (BV3A)’s 12-month stock price forecast through October 2027 has a consensus target of €12.23, implying 15% upside. The forecast is based on price targets from 8 Wall Street analysts.
Past growth per year Not enough data
Average annual growth cannot be calculated for these periods.
Explore analyst estimates, growth and forecast ranges.
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
According to Wall Street analysts, the average 1-year price target for BV3A is 12.23 EUR with a low forecast of 8.97 EUR and a high forecast of 13.53 EUR.
Over the last 13 years, the compound annual growth rate for Revenue has been 15%. The projected CAGR for the next 7 years is 2%.
Over the last 13 years, the compound annual growth rate for Gross Profit has been 15%. The projected CAGR for the next 5 years is 4%.
The compound annual growth rate for Operating Income over the next 7 years is -3%.
The compound annual growth rate for Pre-Tax Income over the next 3 years is -17%.
The compound annual growth rate for Net Income over the next 5 years is -3%.
We rebuilt our DCF valuation models from the ground up and upgraded how Intrinsic Value is calculated. Alpha Spread now selects the method that best fits each company.
You can now see how the new methodology performed across thousands of stocks on our new Valuation Backtest page. We update the results at the end of every month.
AI-generated answers can contain mistakes, outdated facts, or incomplete information. Always verify important details before making decisions.
The AI Assistant is designed for research and education. It does not provide personalized investment, legal, or tax advice.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
Stock intrinsic value is the real worth of a company's stock, based on its financial health and performance.
Instead of looking at the stock's current market price, which can change due to people's opinions and emotions, intrinsic value helps us understand if a stock is truly a good deal or not.
By focusing on the company's actual financial strength, like its earnings and debts, we can make better decisions about which stocks to buy and when.
Read more